Delivery Order SPE2DB22D1106-SPE2DB24FFBK1
Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the medical product Wegovy 2.4 mg/0.75 ml pen (0.75 ml). The contract, which does not have a set-aside designation, has a ceiling value of $3,312.36 and a performance period ending on July 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, for the provision of Wegovy 0.5 mg/0.5 ml pens. The $1,097.08 delivery order is part of a larger indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00, which serves as the primary contracting vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,645.62 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Wegovy 2.4 mg/0.75 ml pens. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen Drug Corp to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,886.08 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 0.5 mg/0.5 ml Wegovy pens. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating...
- This is a $1,788.45 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product Wegovy 1 MG/0.5 ML PEN 0.5ML. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical...
- The U.S. federal government awarded a delivery order contract valued at $3,162.92 to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the supply of Wegovy 2.4 mg/0.75 ml pens. This order was placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a total potential value of up to $999,999,999.00 and runs...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Wegovy 2.4 mg/0.75 ml pens. The contract has a ceiling value of $21,101.60 and runs through February 6, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of...
- This is a $2,521.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Wegovy, a 2.4 mg/0.75 ml pen, with a period of performance through June 25, 2025. The contract is not set-aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a $2,457.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the medication Wegovy 1 mg/0.5 ml pen, with a period of performance through July 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Wegovy 1 mg/0.5 ml pens. The $1,645.62 firm fixed-price contract has a completion date of September 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FFBK1Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $1,645.62 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide the drug Wegovy (2.4 mg/0.75 ml pen, 0.75 ml). This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical and medical products to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 10/9/24, 9:15 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/10/24 |